Curio Wealth’s Intelligent Bio Solutions INBS Stock Holding History

Curio Wealth’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-200	Closed	-$669	–	584
2026 Q1	$669	Hold	200	–	–	﹤0.01%	447
2025 Q4	$996	Hold	200	–	–	﹤0.01%	375
2025 Q3	$2.04K	Buy	+200	New	+$3.22K	﹤0.01%	241

Other funds holding INBS

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Curio Wealth's INBS Position: Q2 2026 in Review

Curio Wealth sold out of Intelligent Bio Solutions (INBS) in Q2 2026, closing a stake of 200 shares — an estimated $669 sold.

Curio Wealth first reported a position in INBS in Q3 2025 and held it in 3 quarters. The position peaked at $2.04K in Q3 2025. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

Curio Wealth reported no remaining Intelligent Bio Solutions position as of Q2 2026 after selling out during the quarter.
Curio Wealth sold 200 Intelligent Bio Solutions shares in Q2 2026, an estimated $669.
Curio Wealth first reported a position in Intelligent Bio Solutions in Q3 2025 and held it in 3 quarters.
Curio Wealth's Intelligent Bio Solutions position peaked at $2.04K in Q3 2025.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on Curio Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.